Endocrine Today


The following articles appeared in the print edition of ENDOCRINE TODAY.

Table of Contents

Practice in Focus: Large, single-specialty practice offers freedom to endocrinologists

Case Challenges

Doing well on the gel: Declining testosterone levels on treatment pose challenge

Ronald Tamler, MD, PhD, MBA

Cover Story

Clinicians seek better outcomes for women with CVD

FDA News

FDA accepts new drug application for empagliflozin, metformin combo therapy

In the Journals

Vitamin D deficiency, type 2 diabetes development lack causal relation

New report highlights osteoporosis prevalence in men, calls for action

Mortality risk related to high BMI similar for blacks, whites

MsFLASH: Success, potential in treating bothersome menopause symptoms

Recommendations released for obesity-related conditions in children

Vagal nerve block improved weight loss for patients with morbid obesity

Postnatal growth may identify infants genetically predisposed to obesity

Overweight, obesity rates plateau for Ireland's primary school-aged children

Polyunsaturated fats may counter cardiometabolic effects of weight gain in healthy adults

Birth weight could factor into high diabetes rates in black population

Blacks with diabetes at higher risk for amputation, PAD complications than whites

Lasers could provide non-invasive method for glucose measurement

Low levels of DHEA predicted CHD risk in elderly men

Meeting News Coverage

Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

Diabetes increased risk for major osteoporotic, hip fracture

Lower estradiol, SHBG levels related to ectopic CV fat volumes in women at midlife

Nonhormonal menopause treatment did not inhibit enzyme related to tamoxifen conversion

FDA approves remote mobile communications device for CGM

Fixed-dose empagliflozin/linagliptin combinations improved HbA1c in type 2 diabetes

Exploration of devices to treat resistant hypertension in progress

Novel bioidentical estradiol vaginal capsule shows promise in pilot study